Atreca to Present at Two Upcoming Investor Conferences
November 14 2019 - 8:00AM
Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company
focused on developing novel therapeutics based on a deep
understanding of the human immune response, today announced that it
will present at two upcoming investor conferences:
- Stifel Healthcare Conference 2019Date:
Tuesday, November 19, 2019Presentation Time: 10:55 a.m.
ESTLocation: New York, NY
- Evercore ISI HealthCONx ConferenceDate:
Tuesday, December 3, 2019Presentation Time: 10:15 a.m. ESTLocation:
Boston, MA
Live audio webcasts of the presentations can be accessed through
the Events & Presentations section of the company's website at
ir.atreca.com. Archived replays of the webcasts will be available
on the company's website for 90 days following each live
presentation.
About Atreca, Inc. Atreca is a
biopharmaceutical company utilizing its differentiated platform to
discover and develop novel antibody-based immunotherapeutics to
treat a range of solid tumor types. Atreca’s discovery platform
relies on the human immune system to discover unique
antibody-target pairs from patients experiencing an active immune
response against their tumors. These unique antibody-target pairs
represent a potentially novel and previously unexplored landscape
of immuno-oncology targets and provide the basis for novel clinical
therapeutic candidates such as ATRC-101, the company’s lead
clinical candidate. The company expects to file an Investigational
New Drug application for ATRC-101 by the end of 2019 and to
commence a Phase 1b study in multiple solid tumor types in early
2020. For more information on Atreca, please visit
www.atreca.com.
ContactsAtreca, Inc. Herb Cross Chief Financial
Officer info@atreca.com
Investors: Alex Gray, 650-779-9251, ext. 251
agray@atreca.com
Source: Atreca, Inc.
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From Apr 2024 to May 2024
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From May 2023 to May 2024